US-China firm Ablaze Pharma nets $75m co-led by Vivo Capital

The fresh round was jointly led by AdvanTech Capital and Vivo Capital, a Palo Alto-based investment firm that backs the US and China healthcare market. 

Related Keywords

China ,San Diego ,California ,United States ,Shanghai ,Hong Kong ,Hongbo Lu ,Alex Qiao ,Ablaze Pharmaceuticals ,Nan Fung Group Life Sciences ,Advantech Capital ,Vivo Capital ,Palo Alto Based ,Nan Fung Group ,Nan Fung Life Sciences ,Pivotal Bioventure Partners China ,Bio Partners ,Samsara Biocapital ,Venrock Healthcare Capital ,Greater China ,Vivo Capital Managing Partner ,